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Abstract The cytochrome bc1 complex catalyzes electron
transfer from ubiquinol to cytochrome c by a protonmotive Q
cycle mechanism in which electron transfer is linked to proton
translocation across the inner mitochondrial membrane. In the
Q cycle mechanism proton translocation is the net result of
topographically segregated reduction of quinone and reoxidation
of quinol on opposite sides of the membrane, with protons being
carried across the membrane as hydrogens on the quinol. The
linkage of proton chemistry to electron transfer during quinol
oxidation and quinone reduction requires pathways for moving
protons to and from the aqueous phase and the hydrophobic
environment in which the quinol and quinone redox reactions
occur. Crystal structures of the mitochondrial cytochrome bc1
complexes in various conformations allow insight into possible
proton conduction pathways. In this review we discuss pathways
for proton conduction linked to ubiquinone redox reactions with
particular reference to recently determined structures of the
yeast bc1 complex.
" 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
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1. Introduction
The cytochrome bc1 (ubiquinol:cytochrome c oxidoreduc-
tase complex) is an energy-transducing enzyme located in the
inner mitochondrial membrane of oxygen utilizing eukaryotic
cells, where it participates in cell respiration. A functionally
similar but structurally simpler version of the bc1 complex is
located in the plasma membrane of a wide variety of bacteria,
where it takes part in respiration, denitri¢cation, nitrogen
¢xation, and cyclic photosynthetic electron transfer, depend-
ing on the species. In all of these organisms the bc1 complex
oxidizes a membrane-localized quinol and reduces a water-
soluble, c-type cytochrome and links this redox reaction to
translocation of protons across the membrane in which the
bc1 complex resides.
The mechanism by which the bc1 complex carries out this
energy-transducing electron transfer is known as the proto-
nmotive Q cycle [1]. The electron transfer pathway intrinsic
to the Q cycle mechanism has been supported by an extensive
body of experimental evidence as summarized elsewhere [2].
In the Q cycle mechanism proton translocation is the net
result of topographically segregated reduction of quinone
and reoxidation of quinol on opposite sides of the membrane,
with protons being carried across the membrane as hydroxy
hydrogen atoms on the quinol. The sites where quinone is
reduced and quinol is oxidized are referred to as center N
and center P, respectively, since they are located toward the
electronegative and electropositive sides of the membrane.
Protons are thus taken up at center N, carried across the
membrane by the quinol, and released at center P.
Ubiquinone and ubiquinol partition exclusively into the
hydrophobic phase of the mitochondrial membrane, owing
to the extreme hydrophobicity of the 30^50 carbon isoprenoid
side-chain. In addition, since the quinone and quinol redox
reactions involve a semiquinone intermediate, it is advanta-
geous to have these reactions localized to a non-aqueous en-
vironment in order to provide a thermodynamic and mecha-
nistic barrier to formation of deleterious oxygen radicals by
aberrant reactivities of the semiquinone [3]. Consequently, the
linkage of proton chemistry to electron transfer during quinol
oxidation at center P and quinone reduction at center N re-
quires mechanisms for moving protons to and from the aque-
ous phase and the hydrophobic environment in which the
quinol and quinone reside.
Cytochrome bc1 complexes from bovine [4,5], chicken [6]
and yeast mitochondria [7] have been crystallized and the
structures determined by X-ray crystallography. The structure
of the yeast complex is especially useful since it provides the
basis for a combined approach by site-directed mutagenesis
and X-ray structure analysis to investigate structure/function
relationships within the enzyme [8,9]. In addition, the yeast
bc1 complex has recently been crystallized with an inhibitor
that is structurally related to an intermediate of ubiquinol
oxidation bound at center P, and this structure provides
new insight into the possible pathways of proton conduction
in that region of the enzyme [10].
2. Structure of the cytochrome bc1 complex
The cytochrome bc1 complex from eukaryotic organisms is
a homodimeric, multi-subunit membrane protein complex
(Fig. 1a). Each monomer contains three catalytic subunits
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carrying prosthetic groups, namely cytochrome b with two
b-type hemes, cytochrome c1 with a c-type heme, and the
Rieske protein (Rip1p) containing a [2Fe^2S] cluster. Up to
eight additional subunits are present in mitochondrial com-
plexes [11]. The 2.3 AI resolution structure of the yeast bc1
complex, which was crystallized with the help of antibody
fragments, is the atomic structure of highest resolution avail-
able so far [7]. It provided a detailed description of substrate-
and inhibitor-binding sites elucidating parts of the enzyme
mechanism and suggesting pathways for proton transfer.
The central domain of the complex is formed by eight
transmembrane helices of cytochrome b per monomer. Cyto-
chrome c1 and the Rieske protein are anchored to this core
via single transmembrane helices; their catalytic domains are
located in the intermembrane space. Two or three single trans-
membrane helices of the small subunits are attached to the
periphery of the catalytic core in the yeast or the bovine
complex, respectively. The so-called hinge protein, a small
acidic subunit probably involved in binding of cytochrome
c, is part of the intermembrane portion of the complex. The
large domain of the complex extruding in the matrix space is
formed by core proteins 1 and 2, and one additional subunit,
Qcr7p, in yeast. Functions for most of the subunits that lack
redox groups are not clear.
The structures clearly show that the bc1 complex is a func-
tional dimer (Fig. 1b). One functional unit is comprised of
cytochrome b and cytochrome c1 of one monomer, whereas
the Rieske protein is connected with its transmembrane an-
chor in the second monomer. In principal, both functional
units are fully active, but a regulatory interplay is discussed
(see below). An important feature of the Rieske protein is the
mobility of its catalytic domain, which was ¢rst shown in the
avian bc1 complex structure, in which the Rieske protein was
either mobile and not visible in the X-ray structure or ¢xed
and thereby resolved in a de¢ned conformation by the use of
an inhibitor [6]. It was proposed that the domain acts as a
mobile electron shuttle, taking up electrons at center P when
bound in the b-position and releasing them to cytochrome c1
after swinging over to the c-position. Several mutagenesis
studies con¢rmed that mobility of the catalytic Rieske domain
is crucial for bc1 complex activity. Mutations that limit the
£exibility of the linker connecting the catalytic Rieske domain
Fig. 1. Structure of the yeast cytochrome bc1 complex [7]. Panel (a) shows the homodimeric complex comprised of the catalytic subunits cyto-
chrome b (blue), Rieske protein (green), and cytochrome c1 (yellow) with their respective co-factors (shown in ball-and-stick representation)
and six additional subunits. Cor1p (blue-violet) and Qcr2p (blue-green) extrude into the matrix (MA), the smaller subunits Qcr6p (cyan), Qcr7p
(red), Qcr8p (magenta), Qcr9p (gray) are laterally attached to the complex. Panel (b) shows the catalytic subunits of one functional unit in the
same orientation as transparent surface presentation. The center P (QP)-speci¢c inhibitor stigmatellin and UQ6 bound at center N (QN) visual-
ize the relative position of the centers in respect to the phospholipid bilayer (orange bars). The arrows mark the positions of the primary sites
of proton chemistry within the membrane, indicating the necessity of pathways for proton exchange with the aqueous environment.
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and its transmembrane anchor result in lower activity of the
complex [8,12^14]. However, it is an open question whether
there is any control or trigger for the movement. Molecular
dynamics simulation predicted a steered but stochastic move-
ment [15]. In contrast, electron paramagnetic resonance stud-
ies of oriented membranes suggest a redox dependent move-
ment of the domain [16]. The true nature of the movement
remains to be elucidated.
The relative orientation of the complex in respect to the
phospholipid bilayer can be judged from several parameters,
such as the percentage of solvent-exposed carbon atoms as a
measure for apolarity of the surface, or a layer of exposed
tryptophans. In the structure of the yeast bc1 complex phos-
pholipid molecules have been identi¢ed, which are bound to
the surface of the complex. They not only indicate the posi-
tion of the complex in the phospholipid bilayer, but their tight
and speci¢c binding suggests speci¢c roles for some of them
for structural and functional integrity of the complex as well
as for its assembly [9].
The sites of ubiquinol oxidation and ubiquinone reduction,
center P and center N, have been structurally described with
site-speci¢c inhibitors [5,7,10,17]. In addition, the structure of
the yeast bc1 complex contained the natural substrate coen-
zyme Q6 (UQ6) bound to center N [7]. Both substrate-binding
sites are located at the border of the hydrophobic core of the
enzyme, therefore, short proton transfer pathways are re-
quired for proton uptake and release upon ubiquinone/ubiqui-
nol redox reactions (Fig. 1b). Details of these binding sites
important for the mechanism will be discussed below.
3. The protonmotive Q cycle
The protonmotive Q cycle, shown in Fig. 2, involves diver-
gent oxidation of two molecules of ubiquinol and recycling of
one electron from each oxidation through the bc1 complex,
while the second electron from each oxidation is passed
through the Rieske iron^sulfur cluster and cytochrome c1 en
route to cytochrome c. The two electrons that are recycled
through the enzyme bring about re-reduction of one molecule
of ubiquinone via a stable semiquinone intermediate. The ox-
idation of two ubiquinol molecules releases four protons to
the intermembrane space, while re-reduction of ubiquinone
results in uptake of two protons from the matrix. As noted
above, these redox reactions and associated proton chemistry
take place at two topographically segregated centers, center N
and center P, which are disposed toward the electronegative
and electropositive surfaces of the bc1 complex (Fig. 1b).
In the ¢rst step of the Q cycle, ubiquinol is oxidized at
center P in a concerted reaction that divergently transfers
the two electrons from ubiquinol to the Rieske iron^sulfur
cluster and the cytochrome bL heme (reactions 1a^1c in Fig.
2). In reaction 2 the reduced Rieske cluster oscillates to with-
in electron transfer distance of cytochrome c1 as discussed
above, allowing electron transfer from the iron^sulfur cluster
to the c1 heme. Two protons are released from center P co-
incident with ubiquinol oxidation. In reaction 3 an electron is
transferred from the bL to bH heme, which in turn reduces
ubiquinone to ubisemiquinone (reaction 4). Following oxida-
tion of a second ubiquinol at center P and reduction of the b
cytochromes the bH heme reduces ubisemiquinone to ubiqui-
nol (reaction 5), accompanied by uptake of two protons at
center N.
The ¢rst step of the Q cycle, oxidation of ubiquinol at
center P, has been proposed to be a concerted reaction, alter-
nating in a controlled manner between the two monomers of
the dimeric enzyme, and the evidence for such has been dis-
cussed elsewhere [18]. The concerted aspect of the reaction
derives from the necessity of coupling the thermodynamically
unfavorable reduction of the Rieske iron^sulfur cluster by an
unstable ubiquinol/ubisemiquinone to the thermodynamically
favorable reduction of the bL heme, following the proposal of
Rich and coworkers [19]. Consequently, the concentration of
semiquinone is so low as to be non-existent as a distinct re-
action intermediate during ubiquinol oxidation at center P.
The concerted reaction involves replacement of the ioniz-
able proton of the imidazole nitrogen of His181 on the Rieske
protein by a hydroxyl group from ubiquinol to form a quinol^
imidazolate complex (reaction 1a in Fig. 2), which simulta-
Fig. 2. The protonmotive Q cycle. Electron transfer reactions are
numbered and circled. Dashed arrows designate movement of ubi-
quinol or ubiquinone between centers N and P and movement of
the iron^sulfur protein between cytochrome b and cytochrome c1.
Solid black bars indicate sites of inhibition by antimycin, UHDBT
and stigmatellin. Oxidation of ubiquinol at center P is depicted as a
concerted reaction, consisting of three component reactions, 1a^c,
shown in red. In reactions 1a^c oxidation of ubiquinol delivers two
electrons divergently to the Rieske cluster and the bL heme and the
resulting ubiquinone leaves center P. In reaction 1a ubiquinol repla-
ces a proton of the imidazole nitrogen of His181 on the Rieske
iron^sulfur protein to form a transient quinol^imidazolate complex.
In reaction 1b the quinol^imidazolate complex forms a hydrogen
bond to Glu272 of cytochrome b to form the electron donor com-
plex. In reaction 1c electrons are transferred simultaneously from
the electron donor complex to the Rieske cluster and the bL heme,
resulting in dissociation of the complex and release of ubiquinone.
In reaction 2 the reduced Rieske cluster oscillates to within electron
transfer distance of cytochrome c1, resulting in electron transfer
from the iron^sulfur cluster to the c1 heme. One proton is released
to the aqueous phase from center P when the Rieske cluster is oxi-
dized by cytochrome c1. The other proton is transferred in parallel
with the electron to heme bL when the protonated Glu272 of cyto-
chrome b dissociates from the electron donor complex and moves
toward the heme propionate of heme bL, from which the proton is
conducted to the aqueous phase via Arg79 of cytochrome b. In re-
action 3 an electron is transferred from the bL to bH heme, which
in turn reduces ubiquinone to ubisemiquinone (reaction 4). Follow-
ing oxidation of a second ubiquinol at center P and reduction of
the b cytochromes the bH heme reduces ubisemiquinone to ubiqui-
nol (reaction 5), accompanied by uptake of two protons at center N.
FEBS 27213 28-5-03 Cyaan Magenta Geel Zwart
C. Hunte et al./FEBS Letters 545 (2003) 39^46 41
neously forms a second hydrogen bond to Glu272 of cyto-
chrome b (reaction 1b in Fig. 2). This results in an electron
donor complex with two hydrogen bonds from the quinol,
conferring partial negative charge on the quinol oxygens,
and allowing essentially simultaneous electron transfer to
the Rieske cluster and the bL heme (reaction 1c in Fig. 2).
It should be noted that the recent X-ray structure of the yeast
complex with a 3-undecyl-2-hydroxy-1,4-dioxobenzoxythiazol
(UHDBT) analog bound showed the stabilization of the neg-
ative charge of the hydroxyquinone at center P, suggesting
that an anti-ferromagnetically coupled ubisemiquinone might
be formed under some conditions [10].
When ubiquinol is oxidized the hydrogen bonds to His181
of the Rieske protein and Glu272 of cytochrome b are broken
and the electron donor complex dissipates. The ubiquinone
that is formed as a result of the oxidation leaves center P
and generally has been assumed to enter the ubiquinone
pool. However, it is possible that ubiquinone remains in the
bc1 complex and that the quinone ring rotates out of center P
and into center N in the opposite half of the dimer. Dissipa-
tion of the electron donor complex also allows the Rieske
protein to oscillate toward cytochrome c1 and Glu272 of cy-
tochrome b to rotate toward the propionate of heme bL, as
discussed below.
A model of the proposed electron donor complex was con-
structed and is shown in Fig. 3a. To generate this model ubi-
quinol was docked into the position occupied by stigmatellin
in the crystal structure of the yeast enzyme (1EZV) and then
submitted to an energy minimization. Evidence that the bind-
ing pockets for stigmatellin and ubiquinol are the same has
been outlined elsewhere [7,20]. After energy minimization the
quinol hydroxyl groups are V2.05 and 2.40 AI from the imi-
dazole nitrogen of His181 and carboxyl oxygen of Glu272,
respectively. This demonstrates the feasibility of the two hy-
drogen bonds requisite to the electron donor complex.
Electron transfer is proposed to occur through the hydro-
gen bond and the imidazole ring to the iron^sulfur cluster and
by tunneling to the porphyrin from the quinol hydroxyl group
that is hydrogen-bonded to Glu272. The closest distance to
the heme porphyrin ring, estimated at 10.6 AI , will be one of
the determinants of the electron transfer rate for the concerted
reaction. The second determinant of the electron transfer rate
is the driving force, vGnet, which is the vG for electron trans-
fer from ubiquinol to the iron^sulfur cluster plus the vG for
electron transfer to the bL heme. These two electron transfer
reactions generate a vGnet that varies from 30.05 to 30.3 eV,
depending on the redox poise of the ubiquinol pool and cy-
tochrome c. With a rate determining distance of 10.6 AI one
can calculate from the Moser^Dutton equation [21] that these
potential increments should result in electron transfer rates
between 1U106 and 2U107 s31. Since these rates are three
to four orders of magnitude greater than the measured rates
of the bc1 complex, one can conclude that the usual applica-
tion of Marcus theory that typically assumes a value for the
reorganization energy (V) = 1 is not applicable to ubiquinol
oxidation at center P. This discrepancy is to be expected if
ubiquinol oxidation is a concerted reaction as proposed.
4. Proton conduction from ubiquinol oxidation at center P
From the crystal structure of the yeast bc1 complex with
stigmatellin bound it can be seen that cytochrome b and the
Rieske protein surround stigmatellin and block direct access
to the aqueous phase [7]. We assume that ubiquinol is sim-
ilarly sequestered from the aqueous phase. Consequently,
there must be some mechanism to conduct protons from the
electron donor complex to the aqueous phase when ubiquinol
is oxidized. Based on the crystal structure of the bc1 complex
with stigmatellin bound [7] and the structure when 3-heptyl-2-
hydroxy-1,4-dioxobenzoxythiazol (HHDBT) is bound at cen-
ter P [10], it appears that the two protons are conducted by
two separate mechanisms. One of these depends on movement
of the Rieske protein, the other depends on movement of
Glu272 of cytochrome b. A notable feature of these proton-
conducting mechanisms is that both protons released from
ubiquinol oxidation move to the aqueous surface with mini-
mal charge separation. One moves with the reduced Rieske
iron^sulfur cluster while the other moves in parallel with an
electron to heme bL.
Ubiquinol cytochrome c reductase activity of the bc1 com-
plex is pH dependent and described by a bell-shaped curve
that can be ¢t by assuming three contributing protonatable
groups with pKa = 5.2, 7.5, and 9.2 [22]. The midpoint poten-
tial of the Rieske iron^sulfur protein exhibits a pH depen-
dence that indicates the oxidized protein has pKa = 7.6 and
9.1 [23]. The crystal structures of the bc1 complex with stig-
matellin bound show that it forms hydrogen bonds to His181
of the Rieske protein and Glu272 of cytochrome b. Taken
together these results suggest that the three protonatable
groups contributing to the pH dependent activity are the car-
boxyl group of Glu272 on cytochrome b, the imidazole nitro-
gen on His181 of the Rieske protein, and the imidazole nitro-
gen on His161 of the Rieske protein, respectively. Formation
of the electron donor complex as discussed above would be
enhanced by deprotonation of both Glu272 and His181, while
deprotonation of His161 would lower the midpoint potential
of the Rieske cluster and thus slow the rate of ubiquinol ox-
idation.
When the Rieske iron^sulfur cluster is reduced the imidazole
nitrogen on His181 of the Rieske protein is protonated. Thus,
the redox reaction is formally a hydrogen transfer from the
quinol, and the Rieske protein acts as both an electron and
proton carrier. As noted above, when the hydrogen bond be-
tween the imidazole nitrogen of His181 and ubiquinol is broken
by oxidation of the quinol, the electron donor complex dissi-
pates and the Rieske protein is able to move proximal to cyto-
chrome c1 [6,24], where it is oxidized. When the iron^sulfur
cluster is oxidized the imidazole nitrogen on His181 becomes
a weak base (pKa = 7.6) and the proton dissociates.
The second proton from ubiquinol oxidation is transferred
to Glu272 when the quinol^carboxylate hydrogen bond is
broken as a result of electron transfer to the bL heme.
When the electron donor complex dissipates Glu272 rotates
170‡ to form a hydrogen bond to a water molecule that is
hydrogen-bonded to a propionate on the porphyrin ring of
heme bL as can be seen in the yeast complex with a UHDBT
analog bound (shown in Fig. 3b). The subsequent proton
release to the aqueous surface is mediated by a hydrogen-
bonded water chain stabilized by cytochrome b residues
Arg79, Asn256, Glu66 and Arg70 [10]. In this manner a pro-
ton is carried more than 16 AI from ubiquinol to the aqueous
surface through a proton conduction pathway that involves as
central elements the conserved amino acid, Glu272, a bound
water, and the porphyrin ring of heme bL. Glu272 is com-
FEBS 27213 28-5-03 Cyaan Magenta Geel Zwart
C. Hunte et al./FEBS Letters 545 (2003) 39^4642
pletely conserved in mitochondrial cytochrome b [25] and the
importance of the residue for proton transfer is supported by
mutagenesis studies as replacement by glutamine abolishes
ubiquinol oxidation in Rhodobacter sphaeroides [26]. Also, ki-
netic studies recently showed that protonation of a group with
pKa of 5.7 blocked catalysis and this e¡ect was assigned to
Glu272 [27].
The movement of Glu272 which is central to this proton
conduction pathway is inferred from the location of Glu272
proximal to stigmatellin in the stigmatellin-liganded yeast bc1
complex [7] and proximal to the heme propionate in the non-
liganded bovine bc1 complex [5] and has been proposed earlier
as an initial step for the release of the second proton [7,28,29].
Experimental support is provided by a recently determined
structure of the yeast bc1 complex with an analog of UHDBT
bound [10], where the 2-OH group on the benzoquinone ring
is hydrogen-bonded to His181 of the Rieske protein, while the
carbonyl group of the benzoquinone ring is facing Glu272.
The latter, devoid of any stabilizing interaction, is rotated
proximal to the heme propionate. This suggests that the ab-
sence of a second OH group on the UHDBT analog, as would
be present on ubiquinol, allows the Glu272 to swing away
from the position it occupies in the electron donor complex.
Furthermore, in this structure a single, hydrogen-bonded
water molecule is present between Glu272 and the heme pro-
pionate A, demonstrating a feasible delivery route of the pro-
ton from the primary acceptor to the heme. The short array of
hydrogen-bonded water molecules stabilized by cytochrome b
Fig. 3. Structural basis for electron transfer and proton conduction at center P. Panel (a) shows ubiquinol hydrogen-bonded to His181 of the
Rieske iron^sulfur protein and Glu272 of cytochrome b in the yeast cytochrome bc1 complex. The view is from the membrane interior, looking
toward center P. Portions of the Rieske protein between residues 160^165 and 178^182 are represented as yellow strands. Portions of cyto-
chrome b that include residues 75^85 and 265^275 are shown as cyan ribbons. The iron^sulfur cluster is at the upper left, with iron and sulfur
atoms colored magenta and yellow. The bL heme is at the lower right, with the iron atom colored magenta. Ubiquinol, the bL heme, His181 of
the Rieske protein, and Arg79 and Glu272 of cytochrome b are shown as stick models, with carbon atoms colored green, oxygen atoms colored
red, and nitrogen atoms colored blue. Dashed white lines indicate hydrogen bonds between the ubiquinol hydroxyl groups and the imidazole
nitrogen of His181 of the Rieske protein and the carboxyl oxygen of Glu272 of cytochrome b, and the distances are indicated in Angstroms.
The distance between the ubiquinol oxygen and the bL heme is similarly indicated. Ubiquinol containing two isoprenyl groups in the side-chain
was docked into the Qp site by replacing stigmatellin in the coordinates for the stigmatellin-liganded yeast enzyme [7]. An energy-minimized
structure for the docked quinol was calculated with the Discover0 program in Insight II0, using molecular dynamics and the CFF91 force-
¢eld. Panel (b) shows the structure of the ubiquinol-binding pocket after Glu272 of cytochrome b moves proximal to the propionate side-chain
of the bL heme as it is in the yeast bc1 complex with bound HHDBT [10]. The dashed white arrow depicts the presumed movement of Glu272
during catalysis to the position proximal to the propionate of the bL heme. A gray ribbon and a gray stick model of Glu272 indicate the posi-
tion of residues 265^275 when Glu272 is hydrogen-bonded to ubiquinol. The position of residues 265^275 after Glu272 has moved proximal to
the heme propionate is indicated by a cyan ribbon and a colored stick model of Glu272. A water molecule is hydrogen-bonded between
Glu272 and the heme propionate allowing a direct proton transfer from the primary proton acceptor Glu272 to the propionate.
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residues Arg79, Asn256, Glu66 and Arg70 has been noted in
both crystal structures of the yeast enzyme [7,10] and has been
suggested as a proton exit pathway from the heme propionate
to the aqueous environment [7,10]. The parallel route of elec-
tron and proton transfer from ubiquinol to the b heme might
be of advantage for electrostatic reasons and may speed up
proton transfer.
5. A proton conduction pathway to ubiquinone reduction at
center N
Binding of the natural substrate UQ6 to the QN site has
been described in the structure of the yeast bc1 complex [7].
The ubiquinone head-group is oriented towards the matrix
and the isoprenoid tail extends along the hydrophobic cleft
Fig. 4. Putative proton uptake pathways for ubiquinone reduction at center N. Panel (a) shows two arrays of hydrogen-bonded water molecules
that connect the bulk solvent at the matrix side with the binding pocket. The entrance to the E/R-pathway is formed by Glu52 of Qcr7p and a
water molecule. The gating residue towards the quinone-binding pocket is Arg218 of cytochrome b. CL is positioned at the entrance to the
CL/K-pathway, for which Lys228 of cytochrome b is the gating residue. Arrows indicate the access sites from the bulk solvent; double-headed
arrows indicate proton transfer between the key residues Arg218 or Lys228 of cytochrome b and UQ6. Side-chains of amino acid residues that
are involved in hydrogen bond interactions or ion pair formation are shown (standard colors). Dashed lines indicate hydrogen bond interac-
tions. Dotted lines are used for hydrogen bond interactions of UQ6 and CL (taken from [9]). Panel (b) shows a surface close-up view of the
cardiolipin-binding site. The dianionic CL (white) and a phosphatidylethanolamine molecule (yellow) are bound in a depression of the surface
of the yeast bc1 complex close to the QN site. These boundary phospholipids contribute to position the complex in the phospholipid bilayer (in-
dicated with dashed lines). The suggested proton uptake from the membrane surface via cardiolipin is schematically indicated.
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reaching into the cavity of the QP site of the second monomer.
The carbonyl oxygen atoms of UQ6 are in hydrogen-bonding
distance to a water molecule as well as Asp229 of cytochrome
b on one side and to a water molecule that is stabilized by
His202 of cytochrome b on the other side. These highly con-
served residues were proposed to stabilize the protein sub-
strate complex [7,29]. For the bovine bc1 complex direct pro-
tonation of quinone by histidine and arginine was proposed
[29]. However, the resolution of the available structure did not
allow determination of the positions of water molecules. Fur-
thermore, it was suggested that the histidine side-chain is mo-
bile and may change orientation upon quinone binding and
release, thereby opening the binding pocket to the bulk sol-
vent. In contrast, based on the high-resolution structure of
the yeast complex it was suggested that not His202 but a
water molecule is the primary proton donor on one side,
and the second proton is either donated by a water molecule
or Asp229 [7,9,20]. The donors have to be re-protonated from
the matrix. As the binding pocket is located at the border of
the transmembrane hydrophobic core and as it lacks a direct
opening to the bulk solvent the uptake requires a short proton
‘wire’ or a hydrogen-bonded ‘network’ from the protein sur-
face [7,9].
Two distinct proton uptake pathways have been suggested
from the study of the yeast bc1 complex, namely the E/R-
pathway and the cardiolipin (CL)/K-pathway (Fig. 4). As
they are located on either side of the substrate and can di-
rectly provide protons to the two carbonyl groups in the de-
scribed orientation, reduction of quinone by heme bH most
likely takes place without major reorientation of the quinone
head-group. Interestingly, CL is positioned at the entrance to
one of them (Fig. 4). Well-de¢ned water molecules are present
in the spacious ubiquinone-binding pocket and each of the
carbonyl groups of the quinone ring is in hydrogen-bonding
distance to a water molecule (Wat31 and Wat36). Further
disordered water molecules are likely to be present in the
two lobes of the binding pocket, which extend to the matrix
side.
The E/R-pathway is located on the His202 oriented side of
the ubiquinone head-group. Here, Arg218 mediates between
the water molecules of the binding pocket with an array of
several water molecules that are connected by hydrogen bonds
and stabilized by interactions with neighboring residues (Fig.
4). Glu52 of Qcr7p is positioned at the exit of this array to a
hydrophilic cavity, which is formed by cytochrome b, subunit
Qcr7p and subunit Qcr8p and is open to the aqueous environ-
ment. Upon reduction of ubiquinone a proton is abstracted
from Arg218, and proton transfer occurs directly via the hy-
drogen-bonded water molecules, thereby allowing replenish-
ment of this proton from the matrix side. The presumed gat-
ing role of Arg218 is supported by the fact that it is highly
conserved and only replaced by lysine in mitochondrial cyto-
chrome b. Further support derives from mutations of Asn223
of cytochrome b, the prokaryotic homolog to Asn208. The
latter is part of the suggested proton-conducting array. An
exchange of this residue to valine in a prokaryotic organism
led to disturbance of the QN kinetics [26].
On the Asp229 oriented side of ubiquinone, Lys228, which
is highly conserved in mitochondrial cytochrome b, is the key
residue for the CL/K-pathway (Fig. 4). Lys228 connects the
water molecules of the binding pocket with the aqueous sol-
vent via a single water molecule, which is present in hydrogen
bond distance between Lys228 and a CL molecule, which is
tightly bound to the protein surface. It was proposed that
during reduction of ubiquinone a proton is abstracted from
Lys228. This will consequently be replenished from the matrix
side either directly by reversible deprotonation of the CL
phosphodiester group B or proton exchange occurs via
Wat415, which is located between phosphodiester group B
of CL and the head-group of the neighboring phospholipid.
Consequently, the boundary phospholipid CL not only en-
sures structural integrity of the QN site, but also provides
the entry point for proton uptake. This allows the direct cou-
pling of the ubiquinone reduction with the proton source at
the membrane surface of the matrix side. It was proposed that
the high surface charge density of bilayer anionic phospholip-
ids acts as a trap or bu¡er that concentrates protons and
passes them directly to a proton-translocating pore [30].
Double and triple mutants of the main CL ligands in yeast,
namely K289L/K296L and K288/K289L/K296L, exhibited a
slow growth phenotype on non-fermentable carbon source
and lower bc1 complex content, indicating that the speci¢c
CL-binding site is important for stability and integrity of
the complex [9]. Further evidence derives from the observa-
tion that CL can restore binding of the QN site-speci¢c inhib-
itor antimycin in delipidated yeast bc1 complex [31]. Further
studies are required to prove the functional role of CL in
gating proton uptake for quinone reduction in addition to
its importance for the structural integrity of the QN site archi-
tecture.
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